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of heart related sudden death in young adults. Myocardial fibrosis seems to be
an independant predictor of adverse events such as sudden death and heart
failure. New methods are available to evaluate myocardial fibrosis such as late
gadolinium enhancement (LGE) detected by cardiovascular magnetic reso-
nance (CMR), impairment of left ventricular global strain (LVGS) and serum
markers of collagen turnover.
Objectives: To find a statistical association between LGE, impairment of
LVGS and serum markers of collagen turnover in a population of adults with
HCM and to create a multimodal analysis of patients with predictable adverse
outcome.
Methods: It is a prospective monocentric study including all consecutives
patients with HCM on cardiomyopathy specialysed center (Marseille). Patients
with covert HCM had at the inclusion a complete clinical evaluation, the anal-
ysis of 2 serum markers of collagen turnover: TIMP-1 (Tissue Inhibitor of
MetalloProteinase 1) and PIII-NP( Procollagen III N-Propeptid), a CMR and
analysis of LVGS.
Results: 78 patients (mean age 50±3 ans, 59 males) were included. LGE
was observed in 44 cases (56%). Mean LVGS was –16.3%±3.85. There was
no significant relationship between GLE, LVGS impairment and serum levels
of TIMP-1 and PIII-NP. TIMP-1 serum levels were significantly higher in
patients with lower left ventricular mass index (LVMI) (p=0.03) and smaller
left ventricular wall thickness (p=0.009).
Conclusion: The analysis of the serum markers of collagen turnover
(TIMP-1 and PIII-NP) did not provide any additional information for the
detection of myocardial fibrosis compared to multimodal imaging analysis
based on GLE and LVGS. The higher level of TIMP-1 in patients with lower
LVMI suggests a stronger activity in collagen turnover and pro fibrotic
activity than in patients with higher LVMI.
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Introduction: TAPSE is a method for evaluation of the right ventric-
ular systolic function by measuring the distance of tricuspid annular move-
ment between end-diastole to end –systole. This parameter has been
studied to identify the value of TAPSE predictive of mortality and re-
hospitalization for decompensated heart failure in patients with dilated
cardiomyopathy.
Material and Results: In our series, 61 patients having dilated cardio-
myopathy were followed for a mean period of 11 months. we found that
patients who died have a lower value of TAPSE than survivors
(10.80±3.27 mm vs. 15.5±5.22 mm, p=0.05). This parameter was also
significantly reduced in patients hospitalized for decompensated heart
failure (12.11±3.18 vs 16.84±5.13 mm mm, p <10-3). We also noted that
a TAPSE <12 was predictive of mortality with a risk of death multiplied
by 13 (p=0.02). After multivariate logistic regression analysis and a model
including the echocardiographic parameters significantly associated with a
death event, we found that the most statistically significant factor was a
TAPSE <12 mm (p=0.07). This parameter is a direct factor of death, if the
duration of follow-up was longer and the number of deaths was more
important. We also concluded that a TAPSE <15 was predictive of hospi-
talization for decompensated heart failure with a risk multiplied by 5.8 (p=0.003)
and a TAPSE <11.5mm was predictive of cardiac event( death, decompen-
satory heart failure, ventricular arrythmia ) with a global risk multiplied by
8 (p=0.001).
Conclusion: Several echocardiographic parameters may have a prognostic
value of cardiomyopathy, the TAPSE is considered an important parameter for
risk stratification in patients with heart failure secondary to dilated cardio-
myopathy.
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Introduction: Abnormalities of right ventricular function play an impor-
tant role in the development of clinical symptoms and the prognosis of
patients with mitral stenosis.
Aims: To assess the immediate effect of percutaneous balloon mitral val-
vuloplasty on right ventricle function. 
Methods: Fifty nine patiens ( mean age: 31,02±8,28 years, 65% female )
with isolated rheumatic mitral stenosis were studied before and 24-48h after
percutaneous balloon mitral valvuloplasty. Indications for percutaneous bal-
loon mitral valvuloplasty were New York Heart class ≥II, planimetered mitral
valve area <1.5cm2, mitral regurgitation ≤ 2, suitable valve morphology, and
absence of concomitant cardiovascular disease requiring surgical correction.
The control group consisted of nine women, none had evidence of cardiovas-
cular disease. Echocardiography was done at the end of the procedure to
assess for perforation. 
Results: There is 55% patients were in New York Heart Association class
II and 15% were in class III before percutaneous balloon mitral valvuloplasty,
the mean mitral valve area was 1,02±0,26cm2, and the mean value of pulmo-
nary systolic arterial pressure was 50,22±26,95 mmHg. Percutaneous balloon
mitral valvuloplasty was successfully completed in 58 patients, there was one
case of severe mitral regurgitation, the mean transmitral gradient decreased
from 13,86±7,40mmHg to 5,59±4,01 mmHg (P<0.0001),the right ventricle Tei
index significantly decreased (P<0.0001), the right ventricle ejection fraction
increased from 50,72±10,72 to 58,68±9,93 mmHg (P<0.0001), excursion of
the tricuspid annular plane remained stable, doppler myocardial velocities at
the septal annulus (S1,S2) were increased (p respective <0.034 and <0.0001)
however at the lateral tricuspid aren’t changing. Dp/DT increased in our study
after percutaneous balloon mitral valvuloplasty (both p<0.0001).
Conclusion: Right ventricular function in mitral stenosis is reversibly
impaired; this is predominantly caused by the hemodynamic consequences of
the valvular defect.
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Background: Intracardiac echocardiography probe can be used trough
esophageal route (ICE-TEE) to monitor left atrial appendage (LAA) closure
without requiring general sedation. 
Methods: The study included 16 consecutive patients (75±7 years) in atrial
fibrillation with high risk of embolism (CHAD-Vasc=5±1.4) that required
LAA closure by Amplatzer Cardiac Plug (ACP). Standard TEE was performed
the day before the device implantation for LAA sizing and excluding throm-
bosis. During the procedure, ICE-TEE was used under local anesthesia to
determine ACP diameter (ACP diameter=1.2*LAA diameter by ICE-TEE)
and monitor ACP positioning. LAA size by ICE-TEE was compared to the
size obtained by fluoroscopy and standard TEE and ACP lobe size after device
implantation by ICE-TEE to cardiac computed tomography (CT). 
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Results: LAA diameter by ICE-TEE did not differ from TEE (21±3 mm
vs. 20±3 mm, r=0.9, P<0.001), while fluoroscopy measurement was lower
(19±3 mm, P<0.05 vs. ICE-TEE and P=0.08 vs. TEE). ACP was successfully
implanted in 13 patients after one device, 2 patients after 2 devices and one
failed because of a complex LAA anatomy. As expected ACP diameter
implanted was 1.2±0.04 (mean=25±3mm, ≤26mm in 10/16 patients) greater
than LAA size measured by ICE-TEE. ACP size by ICE-TEE at the end of the
procedure was similar to cardiac CT measurement (24±3 mm vs. 23±4mm,
R=0.98, p<0.001). Finally, the procedure (mean duration=62±27 minutes, X-
ray exposure=78±53 gray/m²) was safely conducted in all without pericardial
effusion and prosthesis migration. 
Conclusions: ICE-TEE probe through esophageal route without general
sedation may be used for the sizing and the monitoring of ACP device implan-
tation. 
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Background: Among patients presenting with chest pain, troponin eleva-
tion and non obstructed coronary arteries, diagnosis is important for
prognostic stratification and treatment. However, many conditions can lead to
this presentation. We sought to assess the diagnostic value of cardiac magnetic
resonance (CMR) in this setting.
Methods: From January 2009 to December 2012, 108 consecutive patients
with chest pain, troponin elevation and unobstructed coronary arteries on cor-
onary angiography underwent a CMR study with cine imaging, T2 weighted
imaging for detection of inflammation and late gadolinium enhancement
imaging for detection of infarction/fibrosis.
Results: Mean age was 54±17 years and 54 (50%) were men. Mean peak
troponin I level was 5,49±7,3 ng/mL (range: 0, 1 – 40). The median interval
from presentation of chest pain to CMR was 5 days. CMR lead to a formal
diagnosis in 76 (70.3%) patients. The final diagnosis was acute myocarditis in
32 (29,6%) patients, acute myocardial infarction in 24(22.2%) patients, stress
cardiomyopathy in 16 (14.8%) patients, hypertrophic cardiomyopathy in
2 cases (1,8%) and cardiac amyloidosis in 2 case (1,8%).
In 25 (23,1%) patients, the CMR was normal. Patients with normal CMR
had a lower mean peak level of troponin (1.75 ng/mL) than patients who have
abnormal examination (6.69 ng/mL) (p=0.001).
Conclusion: Among patients admitted with chest pain, troponin elevation
and non obstructed coronary arteries, CMR establishes a definite diagnosis in
more than 2/3 of patients and is useful to discriminate patients who need sec-
ondary prevention treatment. Normal CMR seems to be correlated with a
smaller myocardial injury.
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Background: Recent advances in nuclear myocardial perfusion
imaging (MPI) have provided possibility to use dual isotope protocol for
high speed acquisition (DI-HS-MPI) with image quality and radiation
dosimetry similar to those observed with a conventional single isotope
protocol. So far, no study compares the results of DI-HS-MPI to invasive
coronary angiography.
Methods: Over 1-year period (May 2011 to April 2012), A total of
1366 patients received DI-HS-MPI. Patients with invasive coronary angio-
graphy (ICA) within 3 months and patients with low likelihood of coro-
nary artery disease (CAD) to assess normalcy rate were included. The
global summed stress score (SSS), summed rest score (SRS) were calcu-
lated and ICA were analyzed in a blinded to the results of MPI. The main
outcome was the evaluation of patient based diagnostic performance of DI-
HS-MPI to detect or rule out significant CAD (>70% luminal diameter
reduction).
Results: Criteria were fulfilled by 216 patients (73 men, age 65±12 years;
ICA, n=104; normalcy rate, n=112). Exercise-test was performed in 36% of
patients, pharmacological stress with dipyridamole in 48%, and dobutamine in
16%. Prevalence of angiography CAD was 72%. Average exam duration was
20±5 min. Sensitivity was 94%, normalcy rate was 91%, and accuracy was
83% for detecting obstructive CAD. 
Conclusion: In this first comparison of DI-HS-MPI with ICA, we show a
high accuracy for detection of angiographically documented CAD for this new
camera technology and new high speed protocol.
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Aim: to evaluate the prevalence of dobutamine-induced coronary spasm in
patients without known coronary artery disease (CAD), to determine the
potential predictors of spasm amongst those with positive dobutamine stress
echocardiography (DSE) and to assess mid-term clinical outcomes.
Methods: 3952 patients referred to our echocardiography laboratory for
DSE between January 2010 and May 2012 were prospectively investigated.
Those with positive DSE underwent coronary angiograms with systematic
methylergometrine intracoronary injection in case of absence of significant
coronary stenosis or spontaneous occlusive coronary spasm. Patients with
spontaneous occlusive coronary spasm or positive methylergometrine test
but no significant stenoses were enrolled and compared with those with pos-
itive DSE and significant coronary lesions at angiograms but no history of
CAD.
Results: 29 patients with DSE-related vasospasm (19.4% of positive DSE
without known CAD) were compared with 64 patients with significant coro-
nary lesions. They were significantly younger (56 vs 67.7 years; p<0.001), had
less frequently hypertension (27.6% vs 64.1%; p=0.01) and diabetes mellitus
(31% vs 68.8%; p=0.01); conversely they had more frequently dyslipidemia
(79.3% vs 53.1%;p=0.021); they also had a lower ischemic area at peak DSE
(<4 involved segments) at 79.3% vs 48.4% (p=0.006). On multivariate anal-
ysis, dyslipidemia (HR=21.3; 95% CI= [3.45-131.7]; p=0.001), and less than
4 ischemic segments at peak DSE (HR=4.3; 95% CI= [1.14-16.23]; p=0.034)
were found to be independent predictors of coronary spasm rather than signif-
icant coronary lesions. Conversely; hypertension, DM and age>60 were pre-
dictors of significant coronary lesions rather than spam. Long-term actuarial
survival free from adverse events was significantly higher in the group of
patients with coronary spasm at 91% versus 67% (log rank p= 0.027) in
patients with significant coronary disease.
Conclusion: DSE- induced coronary spasm is an important condition asso-
ciated with a good mid-term prognosis; dyslipidemia and lower ischemic area
at peak DSE predicted spasm rather than significant stenoses in patients with
positive DSE and no history of CAD
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Background: Advances in acute myocardial infarction (MI) care result in
decreased MI size and improved left ventricular ejection fraction (LVEF) at
discharge. We sought to examine the determinants of LV remodelling at the
era of optimal reperfusion in an ongoing cohort "PREGICA".
Methods: A total of 110 patients with first MI were examined with cardiac
MRI (CMR) at Day 4±2 and Month 6 after reperfusion for measurement of
LV end-diastolic (EDV) and end-systolic (ESV) volumes, LV ejection fraction
(LVEF) infarct size (IS) and presence and extent of microvascular obstruction
(MVO). LV Remodelling was defined as a >20% increase in 6-month EDV
from baseline values.
Results: All patients were analysed. 41 patients (45%) presented with
Anterior AMI, 26 with Lateral (23%) and 29 with Inferior MI (32%). Mean
age was 54±12y.o (75% male). Mean delay for reperfusion therapy was
115±100min. LV remodelling was observed in 39 patients (36%).
Despite identical EDV, patients with LV remodelling had lower LVEF at
baseline (45%±7 vs 51±8, p<0.01), a bigger IS (42g±20 vs 32±20; p<0.01)
and MVO extent (p<0.01). By multivariate analysis, IS (OR=2.8[1.3-6.0]) and
MVO (OR=3.2[1.8-12.5]) were identified as independent predictors of LV
remodelling
Conclusion: Presence of MVO its extent is a strong predictor of LV
remodelling after acute MI.
118
Cardio-pulmonary exercise echocardiography test (CPEET): a new
exercise test to explore cardio-pulmonary pathophysiology
Damien Guijarro, Nicolas Piriou, Benoit Mottin, Philippe Jaafar, Jean-
Pierre Gueffet, Aurelie Dussauge, Caroline Cueff, Jean-Noel Trochu,
Thierry Le Tourneau
CHU Nantes, Cardiologie, Saint Herblain, France
Objectives: Exercise echocardiography (Ex-Echo) and cardiopulmonary
exercise test (CPET) are essential to investigate complex cardiac or pulmonary
pathologies. Both tests, performed separately, are helpful for diagnostic, pro-
gnostic and therapeutic evaluation. Cardiopulmonary exercise echocardio-
graphy test (CPEET) combining CPET with Ex-Echo is a new comprehensive
test introduced in our laboratory to explore cardio-pulmonary diseases.
Methods: CPEET gas exchanges data were first compared to CPET data.
Patients referred to our department for evaluation of complex valvular
diseases, cardiomyopathy or exertional dyspnea of unknown origin carried out
a CPEET. A comprehensive Ex-Echo was combined to a CPET for one single
cyclo-ergometric exercise in semi-supine position. 
Results: In the first step, 11 patients had both CPET and CPEET in clinical
steady state. No significant differences were found in exercise data (maximal
workload, heart rate, arterial pressure) and gaz exchanges data (VO2, VCO2).
CPEET Peak VO2 correlated tightly with CPET Peak VO2 (r=0.94, p<0,0001).
In the second step, 67 patients (57.3±1.7 years, 38 men) carried out the
CPEET. Indications of CPEET were valvular heart diseases (48 pts, 72%),
cardiomyopathy (10 pts, 15%), exertional dyspnea of unknown origin (6 pts,
9%) and evaluation of pulmonary pressure (3 pts, 4%). Maximal workload
was 113±6 watts, peak oxygen consumption averaged 20±1ml/kg/min (77±2%
of predicted value). Peak VO2 was significantly correlated with peak exercise
LV EF (r=0.53) and with peak cardiac output (r=0.58).
Combination of Ex-Echo and CPET provided a clear improvement of
cardiac-pulmonary evaluation in 30 patients (45%) for diagnostic, prognostic
or therapeutic assessment. 
Conclusion: CPEET is a valid and promising test to perform a comprehen-
sive exercise evaluation of complex cardiac situations in one single examina-
tion. Further studies are needed to better define the place of CPEET in cardio-
pulmonary pathologies. 
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Left ventricular ejection fraction (LVEF) impacts both therapeutic option
and outcome in patients with significant chronic aortic regurgitation (AR).
Left ventricular global longitudinal strain (GLS) has been shown to predict
cardiovascular outcome and this parameter may detect subtle LV dysfunction
before LVEF declines.
Purpose: To assess time-dependent behavior of GLS by speckle-tracking
echocardiography (STE) in asymptomatic patients with significant chronic AR.
Methods: We enrolled 42 patients (47±18 yrs, 33 men) with moderate-
severe and severe chronic AR and 30 age- and gender-matched normal sub-
jects (46±18 yrs, 21 men). A comprehensive echocardiogram was performed,
including parameters of LV mechanics by STE. A subgroup of 18 AR patients
was followed-up for 13.6±3.6 months.
Results: LVEF was similar in both groups (60±4% in AR group vs
61±3% in control group, p=0.27). At baseline, AR patients had higher LV
diameters and volumes, LV mass (all p <0.001) and lower GLS (–17.4
±2.3% vs –19.7±2,8%, p=0.001). At the end of follow-up, all AR
patients remained asymptomatic and had higher LV volumes (LV end-sys-
tolic volume 33±11 ml/m2 vs 29±9 ml/m2, p=0.028, LV end-diastolic
volume 78±20 ml/m2 vs 70±18 ml/m2, p=0.018) but similar indexed LV
mass (144±45 g/m2). Despite similar LVEF, GLS significantly decreased
(–16.0±2.9% vs –17.3±1.7%, p=0.032) during follow-up. GLS at the end-
of-follow-up significantly correlated with baseline LV end-systolic volume
(r=0.53, p=0.024), LVEF (r=–0.48, p=0.043), LV peak apical rotation (r=–0.71,
p=0.001), LV torsion (r=–0.58, p=0.011), and baseline GLS (r=0.64,
p=0.004). At multivariable analysis, only baseline LV peak apical rotation
emerged as an independent determinant of a decreased GLS (p=0.041).
Conclusion: In patients with significant AR and normal LVEF, GLS decreases
during follow-up despite preserved LV mass, geometry and EF. The possible role
of this parameter to predict outcomes in this setting remains to be studied.
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Background: The majority of patients with metabolic syndrome (MS)
have a Framingham high risk score but there are a lot of patients with inter-
mediate risk Framingham score. The aim of this study is to determine the
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